cagrisema cagrilintide semaglutide phase 3 obesity The next frontier in metabolic health: Cagrilintide-Semaglutide and the evolving landscape of therapies Cagrilintide is an amylin analogue

These results suggest that CB0313.1 partially restored the diabetes-induced gut microbial dysbiosis

It stimulates insulin secretion in response to elevated blood sugar levels, suppresses glucagon release, and slows gastric emptying

Consequently, GLP-1 RAs reduce blood glucose and glycated hemoglobin levels, facilitating weight loss and improving blood pressure and lipid profile in T2D patients

One caution worth noting: if you're immunocompromised for any reason, consult a physician before adding any probiotic supplement

Varga, et al., Neurochem

During month two, the majority of patients begin seeing steady downward movement on the scale